Evonik, a German-based specialty chemicals company has published the first edition of the MetAMINO ATLAS displaying the results of 15 performance trials investigating the relative bioavailability of supplementary methionine sources in animal diets
Dr Jan-Olaf Barth, head of the efficient nutrition product line at Evonik said, “For cost-effective purchasing, feed formulation and animal production, precise knowledge about the relative nutritive value of DL-methionine compared with liquid MHA-FA and MHA-Ca is essential. With the MetAMINO ATLAS, we want to support our business partners in making knowledge-based purchase decisions for sustainable and economical livestock operations.”
According to Evonik, the trials were conducted in eleven countries on five continents under different climatic, geographic and farm conditions – in experimental settings as well as at commercial farms with broiler chickens, laying hens, swine and aqua species.
“Across all trials and all species, we found that comparable animal performance criteria were achieved when 100 units of MHA-products were replaced with 65 units of MetAMINO,” said Nils Niedner, product manager of MetAMINO.
The atlas further includes a selection of the latest scientific articles, conference abstracts and peer-reviewed publications regarding the bio-efficacy of the commercially available methionine forms.
